The Iranian Journal of Blood and Cancer (IJBC) endeavors to create a fresh avenue for the advancement of Hematology and Oncology in Iran while establishing a connection between Iranian researchers and their global counterparts. It aims to foster collaboration and exchange of knowledge among scientists worldwide, thereby facilitating the progress of the field.
The journal is accessible through online platforms, offering a remarkable compilation of scholarly manuscripts that delve into diverse dimensions of blood disorders and cancers. These encompass comprehensive inquiries into the fields of epidemiology, etiology, biology, diagnosis, treatment, molecular aspects, clinical genetics, as well as studies on transfusion medicine, hematopoietic stem cell transplantation, cell therapy, immunology, genetics, gene therapy, bioinformatics, and artificial intelligence.
The journal warmly welcomes submissions of original papers, reviews, case reports, and letters to the Editor that revolve around the intricate realms of blood disorders and human malignancies.
 

We also cover subjects related to cancer including:

• Risk factors: lifestyle, gene-environment interactions, molecular triggers, and strategies for reducing the risk. 

• Public health issues: epidemiology, the cost-effectiveness of procedures, health technology assessment, cancer registry, social determinants of health, health needs, quality of life measurements, public and professional education, and cancer control programs. 

• Cancer diagnosis and prognosis: normal and abnormal hematopoiesis, benign and malignant tumors, molecular markers; diagnostic imaging; defining tumor margins; detecting minimal residual disease. 

• New approaches to cancer therapy: rational drug design, gene therapy, immunotherapy, combination therapy, drug resistance, targeting therapies to the individuals, and alternative/complementary medicine. 

• Experimental systems and techniques: cell culture and animal models, genomic and proteomic approaches to studying cancer, cell proliferation and differentiation, apoptosis, and molecular aspects of cytokines. 

• Cancer-associated conditions: pain, cachexia, symptoms associated with treatment (hair loss, anemia, gastrointestinal disorders), psychosocial aspects of cancer. 

• Ethical and legal issues surrounding cancer research: trial design, genetic screening, communicating with patients and families, death issues, research policy, and advocacy. 
 

Legal Disclaimer: 

The views and opinions expressed in the articles published in IJBC are solely those of the respective authors and do not necessarily reflect the views and opinions of "The Iranian Pediatric Hematology and Oncology Society." The presence of advertisements in the journal does not imply any warranty, endorsement, or approval of the products or services described therein. "The Iranian Pediatric Hematology and Oncology Society" disclaims any responsibility for any injury or damage to property resulting from the ideas or products referenced in the articles or advertisements.